Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells

通过靶向干细胞样 CD8 T 细胞恢复衰老 T 细胞免疫力

基本信息

  • 批准号:
    10190752
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-04-01 至 2021-09-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Immunosenescence, the age-associated decline in immunity, leads to increased susceptibility to infection and reduced vaccine efficacies. Most influenza-associated deaths in industrial countries occur among the elderly. Chronic viral infection and age-associated inflammation are known to promote immunosenescence. Immunosenescence of CD8 T cells is characterized by reduced response to immune stimuli, increased terminal differentiation, and elevated expression of co-inhibitor receptors. In contrast, T cells with stem cell-like characteristics survive decades after vaccination and exhibit superior therapeutic effects in immunotherapies. In mice chronically infected by lymphocytic choriomeningitis virus (LCMV), I have identified antiviral CD8 T cells expressing high levels of transcription factor TCF1, which resemble stem cells and can both self-renew and replenish the more terminally differentiated TCF1low CD8 T cells. Moreover, stem cell-like CD8 T cells are critical for long-lasting CD8 T cell response against chronic LCMV infection and provide better protection against re-infection. Thus, Stem cell-like CD8 T cells are ideal targets for developing improved vaccines and immunotherapies against infection in the elderly. However, aging is associated with increased inflammation. Whether age-associated inflammation influences the differentiation of stem cell-like CD8 T cells is unclear. My preliminary data suggest that upon stimulation aged CD8 T cells are more prone to terminal differentiation and exhibits elevated activation of STAT3, a transcription factor that mediates the signaling of several inflammatory cytokines. I have also found evidence that inflammatory cytokine IL-21, STAT3, and Sestrin3 are potential regulators of stem cell-like CD8 T cell differentiation. Thus, I hypothesize that age-associated inflammatory cytokine signaling mediated by STAT3 inhibits the differentiation of stem cell-like CD8 T cells in aged mice by regulating Sestrin3 expression, and can be targeted to rejuvenate aged T cell immunity. In this study, I will use my newly developed in vitro culture system and mouse chronic LCMV infection model, and employ cutting- edge transcriptomic, epigenomic, and gene editing methods to study how aging and inflammation affect the differentiation of stem cell-like CD8 T cells. The results from this study will unveil how age-related inflammatory cytokine pathways regulate the differentiation of stem cell-like CD8 T cells during aging, and facilitate the development of new therapeutic strategies aiming to rejuvenate aged T cell immunity by enhancing stem cell- like CD8 T cell differentiation. My long-term goal is to lead a research group focusing on how to harness T cells to prevent and treat infectious diseases in the elderly. The K99/R00 mechanism will provide me the training, time and resource to gain a sound foothold in the field of immunosenescence and learn new skills through getting expert guidance as well as attending courses, seminars and conferences. !
项目摘要/摘要 免疫衰老是与年龄相关的免疫力下降,会导致更多的人患上 感染和疫苗效力降低。在工业国家中,大多数与流感相关的死亡发生在 老年人。众所周知,慢性病毒感染和与年龄相关的炎症可以促进免疫衰老。 CD8T细胞的免疫衰老的特征是对免疫刺激的反应减弱,而增强 终末分化,共抑制受体表达增加。相比之下,T细胞与干细胞样细胞 这些特征在接种疫苗后存活数十年,并在免疫疗法中显示出优越的治疗效果。 在慢性感染淋巴细胞性脉络膜脑膜炎病毒(LCMV)的小鼠中,我发现了抗病毒CD8T细胞 高表达转录因子TCF1的细胞,这种转录因子类似于干细胞,两者都可以自我更新 补充终末分化程度较高的TCF1low CD8 T细胞。此外,干细胞样CD8T细胞是 对抗慢性LCMV感染和提供更好保护的长效CD8 T细胞至关重要 防止再次感染。因此,干细胞样CD8T细胞是开发改进疫苗和 针对老年人感染的免疫疗法。然而,衰老与炎症增加有关。 年龄相关的炎症是否影响干细胞样CD8T细胞的分化尚不清楚。我的 初步数据表明,在刺激时,老化的CD8 T细胞更容易发生终末分化和 表现出STAT3的激活升高,这是一种转录因子,介导了几种炎症反应的信号转导 细胞因子。我还发现了炎性细胞因子IL-21、STAT3和Sestrin3可能是 干细胞样CD8 T细胞分化的调节因子。因此,我假设与年龄相关的炎症性疾病 STAT3介导的细胞因子信号转导途径抑制老龄小鼠干细胞样CD8T细胞分化 调节Sestrin3的表达,并可靶向恢复衰老的T细胞免疫。在这项研究中,我将使用 我新开发的体外培养系统和小鼠慢性LCMV感染模型,并采用切割法- EDGE转录学、表观基因组学和基因编辑方法研究衰老和炎症如何影响 干细胞样CD8T细胞的分化。这项研究的结果将揭示与年龄相关的炎症 细胞因子途径调节干细胞样CD8T细胞在衰老过程中的分化,并促进 旨在通过增强干细胞来恢复衰老T细胞免疫的新治疗策略的开发 如CD8T细胞分化。我的长期目标是领导一个研究小组,专注于如何利用T细胞 预防和治疗老年人传染病。K99/R00机制将为我提供培训, 有时间和资源在免疫衰老领域站稳脚跟,并通过 获得专家指导以及参加课程、研讨会和会议。 好了!

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tuoqi Wu其他文献

Tuoqi Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tuoqi Wu', 18)}}的其他基金

Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunity
了解与年龄相关的抗病毒 CD8 T 细胞免疫力下降的分子机制
  • 批准号:
    10726485
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
编程干细胞样 CD8 T 细胞以增强针对慢性病毒感染的抗病毒免疫力
  • 批准号:
    10819055
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
编程干细胞样 CD8 T 细胞以增强针对慢性病毒感染的抗病毒免疫力
  • 批准号:
    10687970
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
编程干细胞样 CD8 T 细胞以增强针对慢性病毒感染的抗病毒免疫力
  • 批准号:
    10365756
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells
通过靶向干细胞样 CD8 T 细胞恢复衰老 T 细胞免疫力
  • 批准号:
    10516508
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells
通过靶向干细胞样 CD8 T 细胞恢复衰老 T 细胞免疫力
  • 批准号:
    10005996
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了